1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Germany Pharmaceuticals and Healthcare Report Q1 2016

Germany Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 104 pages

Includes 3 FREE quarterly updates

BMI View: Germany continues to stand as the largest pharmaceutical market in the European region,although modest growth rates due to cost containment measures will continue to weigh on drugmakers'commercial opportunities. In regional terms, the German drug market is to be outpaced by the UK marketthrough the forecast period. However, Germany's pharmaceutical positive balance of trade will continue toexpand in the years ahead, while high rate of research and development in the pharmaceutical sector willcontribute in supporting innovation.

Headline Expenditure Projections

- Pharmaceuticals: EUR44.31bn (USD59.38bn) in 2014 to EUR44.57bn (USD49.03bn) in 2015; 0.6% inlocal currency terms and -17.4% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: EUR317.54bn (USD425.50bn) in 2014 to EUR326.17bn (USD358.78bn) in 2015; +2.7% inlocal currency terms and -15.7% in US dollar terms. Forecast broadly in line with last quarter.

Table Of Contents

Germany Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Germany 2013-2019) 7
SWOT 10
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Germany 2011-2019) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2011-2019) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Germany 2011-2019) 20
Table: Retail Pharmaceutical Expenditure, 2003-2010 (EURbn) 20
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Packages, ms) 21
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Average Price per Pack, EUR) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Germany 2011-2019) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2011-2019) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Germany 2011-2019) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Germany 2013-2019) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Germany 2013-2019) 32
Pharmaceuticals Risk/Reward Index 33
Western Europe Risk/Reward Index 33
Germany Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Intellectual Property Regime 42
Pricing Regime 44
Table: Price Build-Up In The German Pharmaceutical Market 45
Reimbursement Regime 47
Market Overview 51
Healthcare Sector 51
Table: Healthcare Resources (Germany 2009-2014) 54
Table: Healthcare Personnel (Germany 2009-2014) 54
Table: Healthcare Activity (Germany 2009-2014) 55
Research and Development 55
Clinical Trials 61
Epidemiology 62
Competitive Landscape 64
Table: Multinational Market Activity 67
Pharmaceutical Distribution 68
Pharmaceutical Retail Sector 69
Company Profile 70
Bayer Health Care 70
Boehringer Ingelheim 74
GlaxoSmithKline (GSK) 79
Merck KGaA 82
Pfizer 86
STADA Arzneimittel 89
Demographic Forecast 93
Demographic Outlook 93
Table: Population Headline Indicators (Germany 1990-2025) 94
Table: Key Population Ratios (Germany 1990-2025) 94
Table: Urban/Rural Population and Life Expectancy (Germany 1990-2025) 95
Table: Population By Age Group (Germany 1990-2025) 95
Table: Population By Age Group % (Germany 1990-2025) 96
Glossary 98
Methodology 100
Pharmaceutical Expenditure Forecast Model 100
Healthcare Expenditure Forecast Model 100
Notes On Methodology 101
Risk/Reward Index Methodology 102
Index Overview 103
Table: Pharmaceutical Risk/Reward Index Indicators 103
Indicator Weightings 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.